Benling Xu

666 total citations
22 papers, 455 citations indexed

About

Benling Xu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Benling Xu has authored 22 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Benling Xu's work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (5 papers). Benling Xu is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (5 papers). Benling Xu collaborates with scholars based in China, United States and Australia. Benling Xu's co-authors include Long Yuan, Peng Zhao, Peng Yuan, Huijie Fan, Hongyan Ni, Quanli Gao, Xiangyü Li, Xingya Li, Peng Qin and Huijuan Yuan and has published in prestigious journals such as Biochemistry, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Benling Xu

20 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benling Xu China 11 213 191 133 132 41 22 455
Melanie A. Girondo United States 9 272 1.3× 200 1.0× 193 1.5× 74 0.6× 39 1.0× 11 496
Yixin Liu China 9 173 0.8× 158 0.8× 104 0.8× 70 0.5× 46 1.1× 25 362
Xiaoxiao Zuo China 11 191 0.9× 260 1.4× 80 0.6× 158 1.2× 49 1.2× 23 475
Vui Pham United States 5 275 1.3× 223 1.2× 159 1.2× 67 0.5× 75 1.8× 5 447
Karim R. Saab United States 7 309 1.5× 265 1.4× 111 0.8× 100 0.8× 26 0.6× 9 478
Natalie McGregor United States 8 240 1.1× 224 1.2× 140 1.1× 98 0.7× 85 2.1× 8 504
Ruozheng Wang China 12 157 0.7× 141 0.7× 111 0.8× 97 0.7× 84 2.0× 47 412
Jittiporn Chaisaingmongkol United States 10 138 0.6× 227 1.2× 134 1.0× 134 1.0× 52 1.3× 13 419
Ludimila Cavalcante United States 12 238 1.1× 148 0.8× 82 0.6× 60 0.5× 78 1.9× 54 423
Christopher Taylor United States 3 179 0.8× 156 0.8× 206 1.5× 58 0.4× 27 0.7× 6 494

Countries citing papers authored by Benling Xu

Since Specialization
Citations

This map shows the geographic impact of Benling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benling Xu more than expected).

Fields of papers citing papers by Benling Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benling Xu. The network helps show where Benling Xu may publish in the future.

Co-authorship network of co-authors of Benling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Benling Xu. A scholar is included among the top collaborators of Benling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benling Xu. Benling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chengjuan, Tingjie Wang, Jing Yuan, et al.. (2025). Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy. BMC Cancer. 25(1). 674–674.
2.
Xu, Benling, Tingjie Wang, Peng Qin, et al.. (2025). The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis. Scientific Reports. 15(1). 17450–17450. 1 indexed citations
3.
Long, Yuan, Yong Zhang, Tiepeng Li, et al.. (2024). Transient-resting culture after activation enhances the generation of CD8+ stem cell-like memory T cells from peripheral blood mononuclear cells. Translational Oncology. 50. 102138–102138. 1 indexed citations
4.
Fu, Xiaomin, Peng Qin, Yong Zhang, et al.. (2023). The inter-link of ageing, cancer and immunity: findings from real-world retrospective study. Immunity & Ageing. 20(1). 75–75. 9 indexed citations
5.
Wang, Xiaoming, Yangyang Zhang, Sen Wang, et al.. (2022). The role of CXCR3 and its ligands in cancer. Frontiers in Oncology. 12. 1022688–1022688. 52 indexed citations
6.
Han, Lu, Jishuai Zhang, Jian Zhou, et al.. (2021). Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma. Leukemia. 35(10). 3002–3006. 33 indexed citations
7.
8.
Fan, Huijie, Jing Yuan, Xiangyü Li, et al.. (2020). LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Biomedicine & Pharmacotherapy. 125. 109987–109987. 56 indexed citations
9.
10.
11.
Li, Tiepeng, Fang Zhang, Peng Qin, et al.. (2019). Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells. Biochemistry. 58(18). 2293–2296. 5 indexed citations
12.
Zhang, Chengjuan, Junxia Zhang, Qiong Wu, et al.. (2019). Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro. Cancer Cell International. 19(1). 342–342. 26 indexed citations
13.
Zhang, Fang, Tiepeng Li, Lu Han, et al.. (2018). TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells. Biochemical and Biophysical Research Communications. 496(4). 1169–1175. 21 indexed citations
14.
15.
Yuan, Long, Benling Xu, Peng Yuan, et al.. (2017). Tumor-infiltrating CD4+ T cells in patients with gastric cancer. Cancer Cell International. 17(1). 114–114. 31 indexed citations
16.
Fan, Huijie, Jing Li, Yongxu Jia, et al.. (2017). Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 25(7). 1061–1068. 29 indexed citations
17.
Yuan, Peng, Benling Xu, Chengzheng Wang, et al.. (2016). Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer. Oncology Letters. 11(3). 2101–2105. 19 indexed citations
18.
Fu, Xiaomin, Yong Zhang, Quanli Gao, et al.. (2016). Cytokine-Induced Killer Cell Therapy-Associated Idiopathic Thrombocytopenic Purpura: Rare but Noteworthy. Immunotherapy. 8(9). 1003–1009. 1 indexed citations
19.
Xu, Benling, Long Yuan, Quanli Gao, et al.. (2015). Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer. Oncotarget. 6(24). 20592–20603. 68 indexed citations
20.
Fan, Huijie, Benling Xu, Jingjing Wu, et al.. (2012). Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. Tumor Biology. 34(2). 769–778. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie A. Girondo Breakdown of academic impact, for papers by Yixin Liu Breakdown of academic impact, for papers by Xiaoxiao Zuo Breakdown of academic impact, for papers by Vui Pham Breakdown of academic impact, for papers by Karim R. Saab Breakdown of academic impact, for papers by Natalie McGregor Breakdown of academic impact, for papers by Ruozheng Wang Breakdown of academic impact, for papers by Jittiporn Chaisaingmongkol Breakdown of academic impact, for papers by Ludimila Cavalcante Breakdown of academic impact, for papers by Christopher Taylor
Rankless by CCL
2026